#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arterial tortuosity syndrome Necrotising enterocolitis neonatal Hepatocellular carcinoma Autoimmune hepatitis Osteopetrosis Heritable pulmonary arterial hypertension Acute leukaemia Synovial sarcoma Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Prader-Willi syndrome Wolfram syndrome Neuropathy peripheral Mantle cell lymphoma stage II Congenital megacolon Chronic granulomatous disease More trials…

    Learn about Rare Diseases

    Haemophilia B without inhibitors – Trials in Disease Sarcoidosis – Trials in Disease Hereditary hypophosphataemic rickets – Treatment Brain stem glioma – Life with Disease Haemophilia A with anti factor VIII – Basic Information Alport’s syndrome Marginal zone lymphoma refractory – Basic Information Combined immunodeficiency – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Krabbe’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gozetotide Alf-18 Human Serum Albumin 5% Sqy51 Vibegron Cat Epithelium Extract Xtmab-16 Levonorgestrel Rineterkib Cabozantinib Isatuximab Mexiletine Hydrochloride Tirzepatide Fondaparinux Sodium Sparsentan Atropine Sulfate Monohydrate Bupivacaine Vortioxetine Alanine Cx-037231 Tarlatamab More therapies…

    Learn about Your Condition

    Intermittent claudication Pulmonary venous thrombosis Hepatic neoplasm Dementia Alzheimer's type Hip arthroplasty Friedreich's ataxia Benign renal neoplasm Ocular lymphoma Candida infection Hepatocellular carcinoma Vesicoureteric reflux Oesophageal achalasia Cardiac failure congestive Schizoaffective disorder Endolymphatic hydrops More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer metastatic

  • Study of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Encorafenib
    • Cetuximab
    • Pembrolizumab
    Belgium Czechia Denmark France Germany Italy +6

  • Study of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Capecitabine
    • Fluorouracil
    France

  • Study Comparing XL092 and Atezolizumab with Regorafenib for Patients with Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Regorafenib
    • Atezolizumab
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    Belgium France Germany Hungary Poland Portugal +1

  • Study on ABBV-400 with Fluorouracil, Folinic Acid, and Bevacizumab for Adults with Unresectable Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Irinotecan
    • Fluorouracil
    Belgium Germany Spain

  • Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    • HER2 negative breast cancer
    • Hepatobiliary cancer
    • T-cell lymphoma
    Investigated Drugs:
    • Fadraciclib
    Spain

  • Study on the Safety and Efficacy of CR6086 and Balstilimab for Patients with Pretreated Metastatic Colorectal and Other GI Cancers

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Gastrointestinal cancer metastatic
    • Colorectal cancer metastatic
    Investigated Drugs:
    • 4-[1-[[6-[[4-(Trifluoromethyl)Phenyl]Methyl]-6-Azaspiro[2.5]Octane-7-Carbonyl]Amino]Cyclopropyl]Benzoic Acid
    • Balstilimab
    Italy
Previous Page
1 … 9 10 11 12 13 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!